CLEARPOINT NEURO INC. - COMMON STOCK

ClearPoint Neuro Reports First Quarter 2024 Results

07 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore

02 5 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory

29 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System

24 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

23 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

16 4 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency

19 3 2024 08:07:06 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results

12 3 2024 16:05:00 提供 Nasdaq GlobeNewswire

Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System

11 3 2024 08:00:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024

01 3 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock

29 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Launches Proposed Public Offering of Common Stock

28 2 2024 16:45:35 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance and First-in-Human Cases Performed with the New 2.2 Software Version and the Integrated Maestro Brain Model

21 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces Installation and First Procedure Using the ClearPoint Prism® Neuro Laser Therapy System and Navigation System at Kaleida Health in Buffalo

24 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe

22 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Announces FDA Clearance for SmartFrame OR™ Stereotactic System

16 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue

08 1 2024 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Reports Third Quarter 2023 Results

09 11 2023 16:05:01 提供 Nasdaq GlobeNewswire

ClearPoint Neuro to Announce Third Quarter 2023 Results November 9, 2023

26 10 2023 16:05:00 提供 Nasdaq GlobeNewswire

ClearPoint Neuro Reports Second Quarter 2023 Results

08 8 2023 16:05:01 提供 Nasdaq GlobeNewswire